HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1801	2958 BERNEY C, CLAVIEN PA, ROHNER A ENDOCRINE TUMORS - THE STATE OF THE QUESTION SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT. 1993 NOV 13; 123 (45): 2123-2137	0	3	2	113
1802	3117 BERNEY C, KURT AM, KAPANCI Y PANCREATIC ENDOCRINE TUMORS - CORRELATION OF IMMUNOHISTOCHEMISTRY AND CLINICAL FINDINGS SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT. 1994 FEB 5; 124 (5): 179-185	1	1	6	33
1803	5568 Bernier G, Kothary R Prenatal onset of axonopathy in Dystonia musculorum mice DEVELOPMENTAL GENETICS. 1998; 22 (2): 160-168	2	13	7	50
1804	4194 Bernier L, Wang E A prospective view on phosphatases and replicative senescence EXPERIMENTAL GERONTOLOGY. 1996 JAN-APR; 31 (1-2): 13-19	0	6	1	30
1805	5908 Bernier PJ, Parent A Bcl-2 protein as a marker of neuronal immaturity in postnatal primate brain JOURNAL OF NEUROSCIENCE. 1998 APR 1; 18 (7): 2486-2497	2	54	2	46
1806	2691 BERNOCCHI G, GERZELI G, SCHERINI E, VIGNOLA C NEUROPROTECTIVE EFFECTS OF ALPHA-DIHYDROERGOCRYPTINE AGAINST DAMAGES IN THE SUBSTANTIA-NIGRA CAUSED BY SEVERE TREATMENT WITH 1-METHYL-4-PHENYL- 1,2,3,6-TETRAHYDROPYRIDINE ACTA NEUROPATHOLOGICA. 1993 MAR; 85 (4): 404-413	1	21	3	39
1807	4352 Bernstein HG, Kirschke H, Wiederanders B, Pollak KH, Zipress A, et al. The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease - A review MOLECULAR AND CHEMICAL NEUROPATHOLOGY. 1996 APR; 27 (3): 225-247	2	29	7	138
1808	26938 Bernstein HG, Johnson M, Perry RH, LeBeau FEN, Dobrowolny H, et al. Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies NEUROPATHOLOGY. 2011 FEB; 31 (1): 1-10	0	0	18	52
1809	14423 Bernstein SL, Liu DF, Wyttenbach T, Bowers MT, Lee JC, et al. alpha-synuclein: Stable compact and extended monomeric structures and pH dependence of dimer formation JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY. 2004 OCT; 15 (10): 1435-1443	6	33	10	46
1810	15120 Bernstein SL, Wyttenbach T, Baumketner A, Shea JE, Bitan G, et al. Amyloid beta-protein: Monomer structure and early aggregation states of A beta 42 and its Pro(19) alloform JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2005 FEB 23; 127 (7): 2075-2084	6	97	6	63
#	Date / Author / Journal	LCS	GCS	LCR	CR
1811	9359 Berretta S, Munno DW, Benes FM Amygdalar activation alters the hippocampal GABA system: "Partial" modelling for postmortem changes in schizophrenia JOURNAL OF COMPARATIVE NEUROLOGY. 2001 MAR 5; 431 (2): 129-138	2	35	15	90
1812	19735 Berretta S, Pantazopoulos H, Lange N Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia BIOLOGICAL PSYCHIATRY. 2007 OCT 15; 62 (8): 884-893	0	16	4	78
1813	24211 Berretta S, Gisabella B, Benes FM A rodent model of schizophrenia derived from postmortem studies BEHAVIOURAL BRAIN RESEARCH. 2009 DEC 7; 204 (2): 363-368	1	3	12	89
1814	12504 Berriman J, Serpell LC, Oberg KA, Fink AL, Goedert M, et al. Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003 JUL 22; 100 (15): 9034-9038	56	99	17	44
1815	16183 Berrocal A, Montgomery DL, Mackie JT, Storts RW Primitive neuroectodermal tumor in the spinal cord of a Brahman crossbred calf VETERINARY PATHOLOGY. 2005 NOV; 42 (6): 834-836	0	1	3	8
1816	19145 Berrut G, Hommet C, Beauchet O Loss of consciousness in the elderly PSYCHOLOGIE & NEUROPSYCHIATRIE DU VIEILLISSEMENT. 2007 JUN; 5 (2): 101-120	0	1	5	134
1817	1238 BERRY M, HALL S, FOLLOWS R, REES L, GREGSON N, et al. RESPONSE OF AXONS AND GLIA AT THE SITE OF ANASTOMOSIS BETWEEN THE OPTIC-NERVE AND CELLULAR OR ACELLULAR SCIATIC-NERVE GRAFTS JOURNAL OF NEUROCYTOLOGY. 1988 DEC; 17 (6): 727-744	1	58	4	70
1818	9424 Berry M, Gonzalez AM, Clarke W, Greenlees L, Barrett L, et al. Sustained effects of gene-activated matrices after CNS injury MOLECULAR AND CELLULAR NEUROSCIENCE. 2001 APR; 17 (4): 706-716	1	48	5	27
1819	8243 Berry MD, Boulton AA Glyceraldehyde-3-phosphate dehydrogenase and apoptosis JOURNAL OF NEUROSCIENCE RESEARCH. 2000 APR 15; 60 (2): 150-154	2	75	7	63
1820	10032 Berry RW, Quinn B, Johnson N, Cochran EJ, Ghoshal N, et al. Pathological glial tau accumulations in neurodegenerative disease: review and case report NEUROCHEMISTRY INTERNATIONAL. 2001 NOV-DEC; 39 (5-6): 469-479	18	22	35	68
#	Date / Author / Journal	LCS	GCS	LCR	CR
1821	12488 Berry RW, Abraha A, Lagalwar S, LaPointe N, Gamblin TC, et al. Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment BIOCHEMISTRY. 2003 JUL 15; 42 (27): 8325-8331	47	62	10	24
1822	24567 Bersano A, Ballabio E, Lanfranconi S, Boncoraglio GB, Corti S, et al. Clinical Studies in Stem Cells Transplantation for Stroke: A Review CURRENT VASCULAR PHARMACOLOGY. 2010 JAN; 8 (1): 29-34	0	1	15	65
1823	406 BERSON DM, GRAYBIEL AM ORGANIZATION OF THE STRIATE-RECIPIENT ZONE OF THE CATS LATERALIS POSTERIOR-PULVINAR COMPLEX AND ITS RELATIONS WITH THE GENICULOSTRIATE SYSTEM NEUROSCIENCE. 1983; 9 (2): 337-372	5	67	16	100
1824	6159 Bersu ET, Ahmad FJ, Schwei MJ, Baas PW Cytoplasmic abnormalities in cultured cerebellar neurons from the trisomy 16 mouse DEVELOPMENTAL BRAIN RESEARCH. 1998 JUL 1; 109 (1): 115-120	0	6	2	25
1825	23150 Berth SH, Leopold PL, Morfini G Virus-induced neuronal dysfunction and degeneration FRONTIERS IN BIOSCIENCE. 2009 JUN; 14: 5239-5259	1	2	8	209
1826	9782 Berthelier V, Hamilton JB, Chen SM, Wetzel R A microtiter plate assay for polyglutamine aggregate extension ANALYTICAL BIOCHEMISTRY. 2001 AUG 15; 295 (2): 227-236	5	18	16	43
1827	1898 BERTHIER ML, RUIZ A, MASSONE MI, STARKSTEIN SE, LEIGUARDA RC FOREIGN ACCENT SYNDROME - BEHAVIORAL AND ANATOMICAL FINDINGS IN RECOVERED AND NON-RECOVERED PATIENTS APHASIOLOGY. 1991 MAR-APR; 5 (2): 129-147	0	18	2	48
1828	4275 Berthon G Chemical speciation studies in relation to aluminium metabolism and toxicity COORDINATION CHEMISTRY REVIEWS. 1996 MAR; 149: 241-280	5	64	6	250
1829	8223 Berthon G Does human beta A4 exert a protective function against oxidative stress in Alzheimer's disease? MEDICAL HYPOTHESES. 2000 APR; 54 (4): 672-677	9	20	9	78
1830	10922 Berthon G Aluminium speciation in relation to aluminium bioavailability, metabolism and toxicity COORDINATION CHEMISTRY REVIEWS. 2002 JUN 3; 228 (2): 319-341	1	62	20	182
#	Date / Author / Journal	LCS	GCS	LCR	CR
1831	19362 Bertini M, Ferrara M, De Gennaro L, Curcio G, Moroni F, et al. Directional information flows between brain hemispheres during presleep wake and early sleep stages CEREBRAL CORTEX. 2007 AUG; 17 (8): 1970-1978	1	4	2	41
1832	22782 Bertini M, Ferrara M, De Gennaro L, Curcio G, Moroni F, et al. Directional information flows between brain hemispheres across waking, non-REM and REM sleep states: An EEG study BRAIN RESEARCH BULLETIN. 2009 MAR 30; 78 (6): 270-275	0	1	3	39
1833	25838 Bertini S, Ghilardi E, Asso V, Granchi C, Minutolo F, et al. Biphenyl-Derivatives Possessing Tertiary Amino Groups as beta-Secretase (BACE1) Inhibitors LETTERS IN DRUG DESIGN & DISCOVERY. 2010 AUG; 7 (7): 507-515	0	0	2	18
1834	26464 Bertini S, Ghilardi E, Asso V, Granchi C, Minutolo F, et al. BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides BIOORGANIC & MEDICINAL CHEMISTRY. 2010 NOV 15; 18 (22): 7991-7996	0	0	3	26
1835	13689 Bertoli-Avella AM, Oostra BA, Heutink P Chasing genes in Alzheimer's and Parkinson's disease HUMAN GENETICS. 2004 APR; 114 (5): 413-438	10	27	84	305
1836	15093 Bertoncini CW, Jung YS, Fernandez CO, Hoyer W, Griesinger C, et al. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005 FEB 1; 102 (5): 1430-1435	88	173	18	43
1837	15931 Bertoncini CW, Fernandez CO, Griesinger C, Jovin TM, Zweckstetter M Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 SEP 2; 280 (35): 30649-30652	27	37	23	35
1838	19592 Bertoncini CW, Rasia RM, Lamberto GR, Binolfi A, Zweckstetter M, et al. Structural characterization of the intrinsically unfolded protein beta- synuclein, a natural negative regulator of alpha-synuclein aggregation JOURNAL OF MOLECULAR BIOLOGY. 2007 SEP 21; 372 (3): 708-722	9	26	24	71
1839	13691 Bertram L, Tanzi RE Alzheimer's disease: one disorder, too many genes? HUMAN MOLECULAR GENETICS. 2004 APR; 13: R135-R141	20	84	5	67
1840	15198 Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, et al. Family-based association between Alzheimer's disease and variants in UBQLN1 NEW ENGLAND JOURNAL OF MEDICINE. 2005 MAR 3; 352 (9): 884-894	22	106	2	30
#	Date / Author / Journal	LCS	GCS	LCR	CR
1841	15529 Bertram L, Tanzi RE The genetic epidemidogy of neurodegenerative disease JOURNAL OF CLINICAL INVESTIGATION. 2005 JUN; 115 (6): 1449-1457	19	91	32	99
1842	21734 Bertram L, Tanzi RE Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses NATURE REVIEWS NEUROSCIENCE. 2008 OCT; 9 (10): 768-778	25	111	16	110
1843	26898 Bertrand A, Hoang DM, Khan U, Wadghiri YZ From Axonal Transport to Mitochondrial Trafficking: What Can We Learn from Manganese-Enhanced MRI Studies in Mouse Models of Alzheimer's Disease? CURRENT MEDICAL IMAGING REVIEWS. 2011 FEB; 7 (1): 16-27	0	0	19	158
1844	11712 Bertrand E, Lechowicz W, Lewandowska E, Szpak G, Dymecki J, et al. Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease FOLIA NEUROPATHOLOGICA. 2003; 41 (4): 197-207	5	13	10	31
1845	13162 Bertrand E, Lechowicz W, Szpak GM, Lewandowska E, Dymecki J, et al. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia FOLIA NEUROPATHOLOGICA. 2004; 42 (3): 141-150	7	13	13	24
1846	25569 Bertrand J, Plouffe V, Senechal P, Leclerc N THE PATTERN OF HUMAN TAU PHOSPHORYLATION IS THE RESULT OF PRIMING AND FEEDBACK EVENTS IN PRIMARY HIPPOCAMPAL NEURONS NEUROSCIENCE. 2010 JUN 30; 168 (2): 323-334	3	3	29	39
1847	26009 Bertrand J, Senechal P, Zummo-Soucy M, Plouffe V, Leclerc N The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau JOURNAL OF NEUROCHEMISTRY. 2010 SEP; 114 (5): 1353-1367	0	0	29	40
1848	26098 Bessi V, Bagnoli S, Nacmias B, Tedde A, Sorbi S, et al. Semantic dementia associated with mutation V363I in the tau gene JOURNAL OF THE NEUROLOGICAL SCIENCES. 2010 SEP 15; 296 (1-2): 112-114	0	0	15	25
1849	23294 Besson VC Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation BRITISH JOURNAL OF PHARMACOLOGY. 2009 JUL; 157 (5): 695-704	0	0	19	120
1850	15424 Best JD, Jay MT, Otu F, Ma J, Nadin A, et al. Quantitative measurement of changes in amyloid-beta(40) in the rat brain and cerebrospinal fluid following treatment with the gamma- secretase inhibitor LY-411575 [N-2-[(2S)-2-(3,5-difluorophenyl)-2- hydroxyethanoyl]-N-1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H- dibenzo[b,d]azepin-7-yl]-L-alaninamide] JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2005 MAY; 313 (2): 902-908	13	65	13	40
#	Date / Author / Journal	LCS	GCS	LCR	CR
1851	8920 Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease NATURE NEUROSCIENCE. 2000 DEC; 3 (12): 1301-1306	399	1200	6	41
1852	10646 Betarbet R, Sherer TB, Greenamyre JT Animal models of Parkinson's disease BIOESSAYS. 2002 APR; 24 (4): 308-318	55	192	13	89
1853	11271 Betarbet R, Sherer TB, Di Monte DA, Greenamyre JT Mechanistic approaches to Parkinson's disease pathogenesis BRAIN PATHOLOGY. 2002 OCT; 12 (4): 499-510	21	69	29	102
1854	15037 Betarbet R, Sherer TB, Greenamyre JT Ubiquitin-proteasome system and Parkinson's diseases EXPERIMENTAL NEUROLOGY. 2005 FEB; 191: S17-S27	42	89	51	91
1855	17130 Betarbet R, Canet-Aviles RA, Sherer TB, Mastroberardino PG, McLendon C, et al. Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system NEUROBIOLOGY OF DISEASE. 2006 MAY; 22 (2): 404-420	34	82	42	78
1856	21585 Betarbet R, Anderson LR, Gearing M, Gearing M, Hodges TR, et al. Fas-associated factor 1 and Parkinson's disease NEUROBIOLOGY OF DISEASE. 2008 SEP; 31 (3): 309-315	0	2	11	32
1857	12528 Betchen SA, Kaplitt M Future and current surgical therapies in Parkinson's disease CURRENT OPINION IN NEUROLOGY. 2003 AUG; 16 (4): 487-493	6	27	11	76
1858	23310 Bethea CL, Reddy AP, Tokuyama Y, Henderson JA, Lima FB Protective actions of ovarian hormones in the serotonin system of macaques FRONTIERS IN NEUROENDOCRINOLOGY. 2009 JUL; 30 (2): 212-238	0	11	10	142
1859	7862 Bethea JR Spinal cord injury-induced inflammation: a dual-edged sword NEURAL PLASTICITY AND REGENERATION. 2000; 128: 33-42	3	48	2	95
1860	7170 Bethune C, Blum A, Geyer JR, Silber JR, Ho RJY Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1- nitrosourea (CCNU) in rats PHARMACEUTICAL RESEARCH. 1999 JUN; 16 (6): 896-903	0	6	3	26
#	Date / Author / Journal	LCS	GCS	LCR	CR
1861	20428 Bettencourt BR, Hogan CC, Nimali M, Drohan BW Inducible and constitutive heat shock gene expression responds to modification of Hsp70 copy number in Drosophila melanogaster but does not compensate for loss of thermotolerance in Hsp70 null flies BMC BIOLOGY. 2008 JAN 22; 6: Art. No. 5	0	12	1	44
1862	5078 Betts JC, Blackstock WP, Ward MA, Anderton BH Identification of phosphorylation sites on neurofilament proteins by nanoelectrospray mass spectrometry JOURNAL OF BIOLOGICAL CHEMISTRY. 1997 MAY 16; 272 (20): 12922-12927	10	46	21	57
1863	1571 BEVERSDORF DQ, KURZ EM, SENGELAUB DR SEXUAL-ACTIVITY AND THE MORPHOLOGY OF STEROID-SENSITIVE RAT SPINAL MOTONEURONS PHYSIOLOGY & BEHAVIOR. 1990 JAN; 47 (1): 11-17	0	6	4	49
1864	22201 Beyer JL, Young R, Kuchibhatla M, Krishnan KRR Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review INTERNATIONAL REVIEW OF PSYCHIATRY. 2009; 21 (4): 394-409	0	1	17	89
1865	14668 Beyer K, Lao JI, Carrato C, Mate JL, Lopez D, et al. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2004 DEC; 30 (6): 601-607	23	24	23	31
1866	17536 Beyer K, Humbert J, Ferrer A, Lao JI, Carrato C, et al. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease NEUROREPORT. 2006 AUG 21; 17 (12): 1327-1330	10	11	13	25
1867	17550 Beyer K alpha-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers ACTA NEUROPATHOLOGICA. 2006 SEP; 112 (3): 237-251	31	38	93	136
1868	18140 Beyer K Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane CELL BIOCHEMISTRY AND BIOPHYSICS. 2007; 47 (2): 285-299	16	25	106	151
1869	19045 Beyer K, Humbert J, Ferrer A, Lao JI, Latorre P, et al. A variable poly-T sequence modulates alpha-synuclein isoform expression and is associated with aging JOURNAL OF NEUROSCIENCE RESEARCH. 2007 MAY 15; 85 (7): 1538-1546	3	3	17	36
1870	19797 Beyer K, Ariza A Protein aggregation mechanisms in synucleinopathies: Commonalities and differences JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2007 NOV; 66 (11): 965-974	13	14	70	92
#	Date / Author / Journal	LCS	GCS	LCR	CR
1871	20522 Beyer K, Domingo-Sabat M, Lao JI, Carrato C, Ferrer I, et al. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases NEUROGENETICS. 2008 FEB; 9 (1): 15-23	9	11	26	44
1872	21309 Beyer K, Domingo-Sabat M, Humbert J, Carrato C, Ferrer I, et al. Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease NEUROGENETICS. 2008 JUL; 9 (3): 163-172	10	13	36	48
1873	21837 Beyer K, Ariza A The Therapeutical Potential of Alpha-Synuclein Antiaggregatory Agents for Dementia with Lewy Bodies CURRENT MEDICINAL CHEMISTRY. 2008 NOV; 15 (26): 2748-2759	5	6	101	153
1874	22676 Beyer K, Domingo-Sabat M, Ariza A Molecular Pathology of Lewy Body Diseases INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 724-745	6	7	86	145
1875	26530 Beyer K, Domingo-Sabat M, Santos C, Tolosa E, Ferrer I, et al. The decrease of beta-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies BRAIN. 2010 DEC; 133: 3724-3733	0	0	30	41
1876	19453 Beyer MK, Larsen JP, Aarsland D Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies NEUROLOGY. 2007 AUG 21; 69 (8): 747-754	16	26	16	42
1877	22033 Beyer MK, Aarsland D Grey matter atrophy in early versus late dementia in Parkinson's disease PARKINSONISM & RELATED DISORDERS. 2008 DEC; 14 (8): 620-625	2	5	20	44
1878	2163 BEYREUTHER K, BUSH AI, DYRKS T, HILBICH C, KONIG G, et al. MECHANISMS OF AMYLOID DEPOSITION IN ALZHEIMERS-DISEASE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1991 DEC 3; 640: 129-139	9	44	3	59
1879	5403 Beyreuther K, Masters CL Alzheimer's disease - The ins and outs of amyloid-beta NATURE. 1997 OCT 16; 389 (6652): 677-678	8	32	5	15
1880	9049 Beyreuther K, Master CL Alzheimer's disease: Physiological and pathogenetic role of the amyloid precursor protein (APP), its A beta-amyloid domain and free A beta- amyloid peptide NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION. 2001; : 97-117	1	2	14	90
#	Date / Author / Journal	LCS	GCS	LCR	CR
1881	22778 Bezprozvanny I Amyloid Goes Global SCIENCE SIGNALING. 2009 MAR 24; 2 (63): Art. No. pe16	0	2	7	17
1882	24122 Bezprozvanny I, Klockgether T THERAPEUTIC PROSPECTS FOR SPINOCEREBELLAR ATAXIA TYPE 2 AND 3 DRUGS OF THE FUTURE. 2009 DEC; 34 (12): 991-999	0	0	25	124
1883	22450 Bhak G, Lee JH, Hahn JS, Paik SR Granular Assembly of alpha-Synuclein Leading to the Accelerated Amyloid Fibril Formation with Shear Stress PLOS ONE. 2009 JAN 12; 4 (1): Art. No. e4177	3	6	17	59
1884	23763 Bhak G, Choe YJ, Paik SR Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation BMB REPORTS. 2009 SEP 30; 42 (9): 541-551	0	5	29	117
1885	25767 Bhak G, Lee S, Park JW, Cho S, Paik SR Amyloid hydrogel derived from curly protein fibrils of alpha-synuclein BIOMATERIALS. 2010 AUG; 31 (23): 5986-5995	0	1	9	40
1886	19328 Bhang SH, Lee YE, Cho SW, Shim JW, Lee SH, et al. Basic fibroblast growth factor promotes bone marrow stromal cell transplantation-mediated neural regeneration in traumatic brain injury BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007 JUL 20; 359 (1): 40-45	0	5	7	31
1887	26562 Bharadwaj P, Martins R, Macreadie I Yeast as a model for studying Alzheimer's disease FEMS YEAST RESEARCH. 2010 DEC; 10 (8): 961-969	0	1	16	83
1888	14730 Bharate SB, Chauthe SK, Bhutani KK, Singh IP An efficient two-step synthesis of jensenone isolated from Eucalyptus jensenii. Synthesis of analogues and evaluation as antioxidants AUSTRALIAN JOURNAL OF CHEMISTRY. 2005; 58 (7): 551-555	0	4	1	34
1889	15616 Bharath S, Andersen JK Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: Implications for Parkinson's disease ANTIOXIDANTS & REDOX SIGNALING. 2005 JUL-AUG; 7 (7-8): 900-910	5	28	5	36
1890	17571 Bharathi, Bharathi Shamasundar NM, Rao TSS, Naidu MD, Ravid R, et al. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model BRAIN RESEARCH REVIEWS. 2006 SEP; 52 (2): 275-292	0	0	29	168
#	Date / Author / Journal	LCS	GCS	LCR	CR
1891	19567 Bharathi, Bharathi Indi SS, Rao KSJ Copper- and iron-induced differential fibril formation in alpha- synuclein: TEM study NEUROSCIENCE LETTERS. 2007 SEP 7; 424 (2): 78-82	7	0	35	44
1892	21673 Bharathi, Bharathi Nagabhushan P, Rao KSJ Mathematical approach to understand the kinetics of alpha-synuclein aggregation: Relevance to Parkinson's disease COMPUTERS IN BIOLOGY AND MEDICINE. 2008 OCT; 38 (10): 1084-1093	0	0	17	44
1893	22594 Bhardwaj SK, Baharnoori M, Sharif-Askari B, Kamath A, Williams S, et al. Behavioral characterization of dysbindin-1 deficient sandy mice BEHAVIOURAL BRAIN RESEARCH. 2009 FEB 11; 197 (2): 435-441	10	16	22	70
1894	10729 Bharucha DC, Zhou MS, Nekhai S, Brady JN, Shukla RR, et al. A protein phosphatase from human T cells augments Tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat VIROLOGY. 2002 APR 25; 296 (1): 6-16	0	15	1	45
1895	19514 Bhasin M, Rowan E, Edwards K, McKeith I Cholinesterase inhibitors in dementia with Lewy bodies - A comparative analysis INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007 SEP; 22 (9): 890-895	6	10	1	21
1896	16077 Bhaskar K, Yen SH, Lee G Disease-related modifications in tau affect the interaction between Fyn and tau JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 OCT 21; 280 (42): 35119-35125	28	45	31	43
1897	26233 Bhaskar K, Hobbs GA, Yen SH, Lee G Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 OCT; 36 (6): 462-477	0	0	29	41
1898	12972 Bhat R, Xue YF, Berg S, Hellberg S, Ormo M, et al. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418 JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 NOV 14; 278 (46): 45937-45945	28	162	22	52
1899	15186 Bhatt MH, Podder N, Chokroverty S Sleep and neurodegenerative diseases SEMINARS IN NEUROLOGY. 2005 MAR; 25 (1): 39-51	1	8	9	99
1900	26440 Bhattacharjee A, Mulya A, Pal S, Roy B, Feldman GM, et al. Monocyte 15-Lipoxygenase Gene Expression Requires ERK1/2 MAPK Activity JOURNAL OF IMMUNOLOGY. 2010 NOV 1; 185 (9): 5211-5224	0	0	1	80

Date / Author / Journal

LCS

GCS

LCR

1801

2958 BERNEY C, CLAVIEN PA, ROHNER A

ENDOCRINE TUMORS - THE STATE OF THE QUESTION

SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT. 1993 NOV 13; 123 (45): 2123-2137

113

1802

3117 BERNEY C, KURT AM, KAPANCI Y

PANCREATIC ENDOCRINE TUMORS - CORRELATION OF IMMUNOHISTOCHEMISTRY AND CLINICAL FINDINGS

SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT. 1994 FEB 5; 124 (5): 179-185

1803

5568 Bernier G, Kothary R

Prenatal onset of axonopathy in Dystonia musculorum mice

DEVELOPMENTAL GENETICS. 1998; 22 (2): 160-168

1804

4194 Bernier L, Wang E

A prospective view on phosphatases and replicative senescence

EXPERIMENTAL GERONTOLOGY. 1996 JAN-APR; 31 (1-2): 13-19

1805

5908 Bernier PJ, Parent A

Bcl-2 protein as a marker of neuronal immaturity in postnatal primate brain

JOURNAL OF NEUROSCIENCE. 1998 APR 1; 18 (7): 2486-2497

1806

2691 BERNOCCHI G, GERZELI G, SCHERINI E, VIGNOLA C

NEUROPROTECTIVE EFFECTS OF ALPHA-DIHYDROERGOCRYPTINE AGAINST DAMAGES IN THE SUBSTANTIA-NIGRA CAUSED BY SEVERE TREATMENT WITH 1-METHYL-4-PHENYL- 1,2,3,6-TETRAHYDROPYRIDINE

ACTA NEUROPATHOLOGICA. 1993 MAR; 85 (4): 404-413

1807

4352 Bernstein HG, Kirschke H, Wiederanders B, Pollak KH, Zipress A, et al.

The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease - A review

MOLECULAR AND CHEMICAL NEUROPATHOLOGY. 1996 APR; 27 (3): 225-247

138

1808

26938 Bernstein HG, Johnson M, Perry RH, LeBeau FEN, Dobrowolny H, et al.

Partial loss of parvalbumin-containing hippocampal interneurons in dementia with Lewy bodies

NEUROPATHOLOGY. 2011 FEB; 31 (1): 1-10

1809

14423 Bernstein SL, Liu DF, Wyttenbach T, Bowers MT, Lee JC, et al.

alpha-synuclein: Stable compact and extended monomeric structures and pH dependence of dimer formation

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY. 2004 OCT; 15 (10): 1435-1443

1810

15120 Bernstein SL, Wyttenbach T, Baumketner A, Shea JE, Bitan G, et al.

Amyloid beta-protein: Monomer structure and early aggregation states of A beta 42 and its Pro(19) alloform

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 2005 FEB 23; 127 (7): 2075-2084

Date / Author / Journal

LCS

GCS

LCR

1811

9359 Berretta S, Munno DW, Benes FM

Amygdalar activation alters the hippocampal GABA system: "Partial" modelling for postmortem changes in schizophrenia

JOURNAL OF COMPARATIVE NEUROLOGY. 2001 MAR 5; 431 (2): 129-138

1812

19735 Berretta S, Pantazopoulos H, Lange N

Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia

BIOLOGICAL PSYCHIATRY. 2007 OCT 15; 62 (8): 884-893

1813

24211 Berretta S, Gisabella B, Benes FM

A rodent model of schizophrenia derived from postmortem studies

BEHAVIOURAL BRAIN RESEARCH. 2009 DEC 7; 204 (2): 363-368

1814

12504 Berriman J, Serpell LC, Oberg KA, Fink AL, Goedert M, et al.

Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2003 JUL 22; 100 (15): 9034-9038

1815

16183 Berrocal A, Montgomery DL, Mackie JT, Storts RW

Primitive neuroectodermal tumor in the spinal cord of a Brahman crossbred calf

VETERINARY PATHOLOGY. 2005 NOV; 42 (6): 834-836

1816

19145 Berrut G, Hommet C, Beauchet O

Loss of consciousness in the elderly

PSYCHOLOGIE & NEUROPSYCHIATRIE DU VIEILLISSEMENT. 2007 JUN; 5 (2): 101-120

134

1817

1238 BERRY M, HALL S, FOLLOWS R, REES L, GREGSON N, et al.

RESPONSE OF AXONS AND GLIA AT THE SITE OF ANASTOMOSIS BETWEEN THE OPTIC-NERVE AND CELLULAR OR ACELLULAR SCIATIC-NERVE GRAFTS

JOURNAL OF NEUROCYTOLOGY. 1988 DEC; 17 (6): 727-744

1818

9424 Berry M, Gonzalez AM, Clarke W, Greenlees L, Barrett L, et al.

Sustained effects of gene-activated matrices after CNS injury

MOLECULAR AND CELLULAR NEUROSCIENCE. 2001 APR; 17 (4): 706-716

1819

8243 Berry MD, Boulton AA

Glyceraldehyde-3-phosphate dehydrogenase and apoptosis

JOURNAL OF NEUROSCIENCE RESEARCH. 2000 APR 15; 60 (2): 150-154

1820

10032 Berry RW, Quinn B, Johnson N, Cochran EJ, Ghoshal N, et al.

Pathological glial tau accumulations in neurodegenerative disease: review and case report

NEUROCHEMISTRY INTERNATIONAL. 2001 NOV-DEC; 39 (5-6): 469-479

Date / Author / Journal

LCS

GCS

LCR

1821

12488 Berry RW, Abraha A, Lagalwar S, LaPointe N, Gamblin TC, et al.

Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment

BIOCHEMISTRY. 2003 JUL 15; 42 (27): 8325-8331

1822

24567 Bersano A, Ballabio E, Lanfranconi S, Boncoraglio GB, Corti S, et al.

Clinical Studies in Stem Cells Transplantation for Stroke: A Review

CURRENT VASCULAR PHARMACOLOGY. 2010 JAN; 8 (1): 29-34

1823

406 BERSON DM, GRAYBIEL AM

ORGANIZATION OF THE STRIATE-RECIPIENT ZONE OF THE CATS LATERALIS POSTERIOR-PULVINAR COMPLEX AND ITS RELATIONS WITH THE GENICULOSTRIATE SYSTEM

NEUROSCIENCE. 1983; 9 (2): 337-372

100

1824

6159 Bersu ET, Ahmad FJ, Schwei MJ, Baas PW

Cytoplasmic abnormalities in cultured cerebellar neurons from the trisomy 16 mouse

DEVELOPMENTAL BRAIN RESEARCH. 1998 JUL 1; 109 (1): 115-120

1825

23150 Berth SH, Leopold PL, Morfini G

Virus-induced neuronal dysfunction and degeneration

FRONTIERS IN BIOSCIENCE. 2009 JUN; 14: 5239-5259

209

1826

9782 Berthelier V, Hamilton JB, Chen SM, Wetzel R

A microtiter plate assay for polyglutamine aggregate extension

ANALYTICAL BIOCHEMISTRY. 2001 AUG 15; 295 (2): 227-236

1827

1898 BERTHIER ML, RUIZ A, MASSONE MI, STARKSTEIN SE, LEIGUARDA RC

FOREIGN ACCENT SYNDROME - BEHAVIORAL AND ANATOMICAL FINDINGS IN RECOVERED AND NON-RECOVERED PATIENTS

APHASIOLOGY. 1991 MAR-APR; 5 (2): 129-147

1828

4275 Berthon G

Chemical speciation studies in relation to aluminium metabolism and toxicity

COORDINATION CHEMISTRY REVIEWS. 1996 MAR; 149: 241-280

250

1829

8223 Berthon G

Does human beta A4 exert a protective function against oxidative stress in Alzheimer's disease?

MEDICAL HYPOTHESES. 2000 APR; 54 (4): 672-677

1830

10922 Berthon G

Aluminium speciation in relation to aluminium bioavailability, metabolism and toxicity

COORDINATION CHEMISTRY REVIEWS. 2002 JUN 3; 228 (2): 319-341

182

Date / Author / Journal

LCS

GCS

LCR

1831

19362 Bertini M, Ferrara M, De Gennaro L, Curcio G, Moroni F, et al.

Directional information flows between brain hemispheres during presleep wake and early sleep stages

CEREBRAL CORTEX. 2007 AUG; 17 (8): 1970-1978

1832

22782 Bertini M, Ferrara M, De Gennaro L, Curcio G, Moroni F, et al.

Directional information flows between brain hemispheres across waking, non-REM and REM sleep states: An EEG study

BRAIN RESEARCH BULLETIN. 2009 MAR 30; 78 (6): 270-275

1833

25838 Bertini S, Ghilardi E, Asso V, Granchi C, Minutolo F, et al.

Biphenyl-Derivatives Possessing Tertiary Amino Groups as beta-Secretase (BACE1) Inhibitors

LETTERS IN DRUG DESIGN & DISCOVERY. 2010 AUG; 7 (7): 507-515

1834

26464 Bertini S, Ghilardi E, Asso V, Granchi C, Minutolo F, et al.

BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides

BIOORGANIC & MEDICINAL CHEMISTRY. 2010 NOV 15; 18 (22): 7991-7996

1835

13689 Bertoli-Avella AM, Oostra BA, Heutink P

Chasing genes in Alzheimer's and Parkinson's disease

HUMAN GENETICS. 2004 APR; 114 (5): 413-438

305

1836

15093 Bertoncini CW, Jung YS, Fernandez CO, Hoyer W, Griesinger C, et al.

Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2005 FEB 1; 102 (5): 1430-1435

173

1837

15931 Bertoncini CW, Fernandez CO, Griesinger C, Jovin TM, Zweckstetter M

Familial mutants of alpha-synuclein with increased neurotoxicity have a destabilized conformation

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 SEP 2; 280 (35): 30649-30652

1838

19592 Bertoncini CW, Rasia RM, Lamberto GR, Binolfi A, Zweckstetter M, et al.

Structural characterization of the intrinsically unfolded protein beta- synuclein, a natural negative regulator of alpha-synuclein aggregation

JOURNAL OF MOLECULAR BIOLOGY. 2007 SEP 21; 372 (3): 708-722

1839

13691 Bertram L, Tanzi RE

Alzheimer's disease: one disorder, too many genes?

HUMAN MOLECULAR GENETICS. 2004 APR; 13: R135-R141

1840

15198 Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, et al.

Family-based association between Alzheimer's disease and variants in UBQLN1

NEW ENGLAND JOURNAL OF MEDICINE. 2005 MAR 3; 352 (9): 884-894

106

Date / Author / Journal

LCS

GCS

LCR

1841

15529 Bertram L, Tanzi RE

The genetic epidemidogy of neurodegenerative disease

JOURNAL OF CLINICAL INVESTIGATION. 2005 JUN; 115 (6): 1449-1457

1842

21734 Bertram L, Tanzi RE

Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses

NATURE REVIEWS NEUROSCIENCE. 2008 OCT; 9 (10): 768-778

111

110

1843

26898 Bertrand A, Hoang DM, Khan U, Wadghiri YZ

From Axonal Transport to Mitochondrial Trafficking: What Can We Learn from Manganese-Enhanced MRI Studies in Mouse Models of Alzheimer's Disease?

CURRENT MEDICAL IMAGING REVIEWS. 2011 FEB; 7 (1): 16-27

158

1844

11712 Bertrand E, Lechowicz W, Lewandowska E, Szpak G, Dymecki J, et al.

Degenerative axonal changes in the hippocampus and amygdala in Parkinson's disease

FOLIA NEUROPATHOLOGICA. 2003; 41 (4): 197-207

1845

13162 Bertrand E, Lechowicz W, Szpak GM, Lewandowska E, Dymecki J, et al.

Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia

FOLIA NEUROPATHOLOGICA. 2004; 42 (3): 141-150

1846

25569 Bertrand J, Plouffe V, Senechal P, Leclerc N

THE PATTERN OF HUMAN TAU PHOSPHORYLATION IS THE RESULT OF PRIMING AND FEEDBACK EVENTS IN PRIMARY HIPPOCAMPAL NEURONS

NEUROSCIENCE. 2010 JUN 30; 168 (2): 323-334

1847

26009 Bertrand J, Senechal P, Zummo-Soucy M, Plouffe V, Leclerc N

The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau

JOURNAL OF NEUROCHEMISTRY. 2010 SEP; 114 (5): 1353-1367

1848

26098 Bessi V, Bagnoli S, Nacmias B, Tedde A, Sorbi S, et al.

Semantic dementia associated with mutation V363I in the tau gene

JOURNAL OF THE NEUROLOGICAL SCIENCES. 2010 SEP 15; 296 (1-2): 112-114

1849

23294 Besson VC

Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation

BRITISH JOURNAL OF PHARMACOLOGY. 2009 JUL; 157 (5): 695-704

120

1850

15424 Best JD, Jay MT, Otu F, Ma J, Nadin A, et al.

Quantitative measurement of changes in amyloid-beta(40) in the rat brain and cerebrospinal fluid following treatment with the gamma- secretase inhibitor LY-411575 [N-2-[(2S)-2-(3,5-difluorophenyl)-2- hydroxyethanoyl]-N-1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H- dibenzo[b,d]azepin-7-yl]-L-alaninamide]

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2005 MAY; 313 (2): 902-908

Date / Author / Journal

LCS

GCS

LCR

1851

8920 Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al.

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

NATURE NEUROSCIENCE. 2000 DEC; 3 (12): 1301-1306

399

1200

1852

10646 Betarbet R, Sherer TB, Greenamyre JT

Animal models of Parkinson's disease

BIOESSAYS. 2002 APR; 24 (4): 308-318

192

1853

11271 Betarbet R, Sherer TB, Di Monte DA, Greenamyre JT

Mechanistic approaches to Parkinson's disease pathogenesis

BRAIN PATHOLOGY. 2002 OCT; 12 (4): 499-510

102

1854

15037 Betarbet R, Sherer TB, Greenamyre JT

Ubiquitin-proteasome system and Parkinson's diseases

EXPERIMENTAL NEUROLOGY. 2005 FEB; 191: S17-S27

1855

17130 Betarbet R, Canet-Aviles RA, Sherer TB, Mastroberardino PG, McLendon C, et al.

Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system

NEUROBIOLOGY OF DISEASE. 2006 MAY; 22 (2): 404-420

1856

21585 Betarbet R, Anderson LR, Gearing M, Gearing M, Hodges TR, et al.

Fas-associated factor 1 and Parkinson's disease

NEUROBIOLOGY OF DISEASE. 2008 SEP; 31 (3): 309-315

1857

12528 Betchen SA, Kaplitt M

Future and current surgical therapies in Parkinson's disease

CURRENT OPINION IN NEUROLOGY. 2003 AUG; 16 (4): 487-493

1858

23310 Bethea CL, Reddy AP, Tokuyama Y, Henderson JA, Lima FB

Protective actions of ovarian hormones in the serotonin system of macaques

FRONTIERS IN NEUROENDOCRINOLOGY. 2009 JUL; 30 (2): 212-238

142

1859

7862 Bethea JR

Spinal cord injury-induced inflammation: a dual-edged sword

NEURAL PLASTICITY AND REGENERATION. 2000; 128: 33-42

1860

7170 Bethune C, Blum A, Geyer JR, Silber JR, Ho RJY

Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1- nitrosourea (CCNU) in rats

PHARMACEUTICAL RESEARCH. 1999 JUN; 16 (6): 896-903

Date / Author / Journal

LCS

GCS

LCR

1861

20428 Bettencourt BR, Hogan CC, Nimali M, Drohan BW

Inducible and constitutive heat shock gene expression responds to modification of Hsp70 copy number in Drosophila melanogaster but does not compensate for loss of thermotolerance in Hsp70 null flies

BMC BIOLOGY. 2008 JAN 22; 6: Art. No. 5

1862

5078 Betts JC, Blackstock WP, Ward MA, Anderton BH

Identification of phosphorylation sites on neurofilament proteins by nanoelectrospray mass spectrometry

JOURNAL OF BIOLOGICAL CHEMISTRY. 1997 MAY 16; 272 (20): 12922-12927

1863

1571 BEVERSDORF DQ, KURZ EM, SENGELAUB DR

SEXUAL-ACTIVITY AND THE MORPHOLOGY OF STEROID-SENSITIVE RAT SPINAL MOTONEURONS

PHYSIOLOGY & BEHAVIOR. 1990 JAN; 47 (1): 11-17

1864

22201 Beyer JL, Young R, Kuchibhatla M, Krishnan KRR

Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review

INTERNATIONAL REVIEW OF PSYCHIATRY. 2009; 21 (4): 394-409

1865

14668 Beyer K, Lao JI, Carrato C, Mate JL, Lopez D, et al.

Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2004 DEC; 30 (6): 601-607

1866

17536 Beyer K, Humbert J, Ferrer A, Lao JI, Carrato C, et al.

Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease

NEUROREPORT. 2006 AUG 21; 17 (12): 1327-1330

1867

17550 Beyer K

alpha-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

ACTA NEUROPATHOLOGICA. 2006 SEP; 112 (3): 237-251

136

1868

18140 Beyer K

Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane

CELL BIOCHEMISTRY AND BIOPHYSICS. 2007; 47 (2): 285-299

106

151

1869

19045 Beyer K, Humbert J, Ferrer A, Lao JI, Latorre P, et al.

A variable poly-T sequence modulates alpha-synuclein isoform expression and is associated with aging

JOURNAL OF NEUROSCIENCE RESEARCH. 2007 MAY 15; 85 (7): 1538-1546

1870

19797 Beyer K, Ariza A

Protein aggregation mechanisms in synucleinopathies: Commonalities and differences

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. 2007 NOV; 66 (11): 965-974

Date / Author / Journal

LCS

GCS

LCR

1871

20522 Beyer K, Domingo-Sabat M, Lao JI, Carrato C, Ferrer I, et al.

Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases

NEUROGENETICS. 2008 FEB; 9 (1): 15-23

1872

21309 Beyer K, Domingo-Sabat M, Humbert J, Carrato C, Ferrer I, et al.

Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease

NEUROGENETICS. 2008 JUL; 9 (3): 163-172

1873

21837 Beyer K, Ariza A

The Therapeutical Potential of Alpha-Synuclein Antiaggregatory Agents for Dementia with Lewy Bodies

CURRENT MEDICINAL CHEMISTRY. 2008 NOV; 15 (26): 2748-2759

101

153

1874

22676 Beyer K, Domingo-Sabat M, Ariza A

Molecular Pathology of Lewy Body Diseases

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2009 MAR; 10 (3): 724-745

145

1875

26530 Beyer K, Domingo-Sabat M, Santos C, Tolosa E, Ferrer I, et al.

The decrease of beta-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies

BRAIN. 2010 DEC; 133: 3724-3733

1876

19453 Beyer MK, Larsen JP, Aarsland D

Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies

NEUROLOGY. 2007 AUG 21; 69 (8): 747-754

1877

22033 Beyer MK, Aarsland D

Grey matter atrophy in early versus late dementia in Parkinson's disease

PARKINSONISM & RELATED DISORDERS. 2008 DEC; 14 (8): 620-625

1878

2163 BEYREUTHER K, BUSH AI, DYRKS T, HILBICH C, KONIG G, et al.

MECHANISMS OF AMYLOID DEPOSITION IN ALZHEIMERS-DISEASE

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1991 DEC 3; 640: 129-139

1879

5403 Beyreuther K, Masters CL

Alzheimer's disease - The ins and outs of amyloid-beta

NATURE. 1997 OCT 16; 389 (6652): 677-678

1880

9049 Beyreuther K, Master CL

Alzheimer's disease: Physiological and pathogenetic role of the amyloid precursor protein (APP), its A beta-amyloid domain and free A beta- amyloid peptide

NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION. 2001; : 97-117

Date / Author / Journal

1881

SCIENCE SIGNALING. 2009 MAR 24; 2 (63): Art. No. pe16

1882

24122 Bezprozvanny I, Klockgether T

THERAPEUTIC PROSPECTS FOR SPINOCEREBELLAR ATAXIA TYPE 2 AND 3

DRUGS OF THE FUTURE. 2009 DEC; 34 (12): 991-999

124

1883

22450 Bhak G, Lee JH, Hahn JS, Paik SR

Granular Assembly of alpha-Synuclein Leading to the Accelerated Amyloid Fibril Formation with Shear Stress

PLOS ONE. 2009 JAN 12; 4 (1): Art. No. e4177

1884

23763 Bhak G, Choe YJ, Paik SR

Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation

BMB REPORTS. 2009 SEP 30; 42 (9): 541-551

117

1885

25767 Bhak G, Lee S, Park JW, Cho S, Paik SR

Amyloid hydrogel derived from curly protein fibrils of alpha-synuclein

BIOMATERIALS. 2010 AUG; 31 (23): 5986-5995

1886

19328 Bhang SH, Lee YE, Cho SW, Shim JW, Lee SH, et al.

Basic fibroblast growth factor promotes bone marrow stromal cell transplantation-mediated neural regeneration in traumatic brain injury

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2007 JUL 20; 359 (1): 40-45

1887

26562 Bharadwaj P, Martins R, Macreadie I

Yeast as a model for studying Alzheimer's disease

FEMS YEAST RESEARCH. 2010 DEC; 10 (8): 961-969

1888

14730 Bharate SB, Chauthe SK, Bhutani KK, Singh IP

An efficient two-step synthesis of jensenone isolated from Eucalyptus jensenii. Synthesis of analogues and evaluation as antioxidants

AUSTRALIAN JOURNAL OF CHEMISTRY. 2005; 58 (7): 551-555

1889

15616 Bharath S, Andersen JK

Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: Implications for Parkinson's disease

ANTIOXIDANTS & REDOX SIGNALING. 2005 JUL-AUG; 7 (7-8): 900-910

1890

17571 Bharathi, Bharathi Shamasundar NM, Rao TSS, Naidu MD, Ravid R, et al.

A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model

BRAIN RESEARCH REVIEWS. 2006 SEP; 52 (2): 275-292

168

Date / Author / Journal

LCS

GCS

LCR

1891

19567 Bharathi, Bharathi Indi SS, Rao KSJ

Copper- and iron-induced differential fibril formation in alpha- synuclein: TEM study

NEUROSCIENCE LETTERS. 2007 SEP 7; 424 (2): 78-82

1892

21673 Bharathi, Bharathi Nagabhushan P, Rao KSJ

Mathematical approach to understand the kinetics of alpha-synuclein aggregation: Relevance to Parkinson's disease

COMPUTERS IN BIOLOGY AND MEDICINE. 2008 OCT; 38 (10): 1084-1093

1893

22594 Bhardwaj SK, Baharnoori M, Sharif-Askari B, Kamath A, Williams S, et al.

Behavioral characterization of dysbindin-1 deficient sandy mice

BEHAVIOURAL BRAIN RESEARCH. 2009 FEB 11; 197 (2): 435-441

1894

10729 Bharucha DC, Zhou MS, Nekhai S, Brady JN, Shukla RR, et al.

A protein phosphatase from human T cells augments Tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat

VIROLOGY. 2002 APR 25; 296 (1): 6-16

1895

19514 Bhasin M, Rowan E, Edwards K, McKeith I

Cholinesterase inhibitors in dementia with Lewy bodies - A comparative analysis

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2007 SEP; 22 (9): 890-895

1896

16077 Bhaskar K, Yen SH, Lee G

Disease-related modifications in tau affect the interaction between Fyn and tau

JOURNAL OF BIOLOGICAL CHEMISTRY. 2005 OCT 21; 280 (42): 35119-35125

1897

26233 Bhaskar K, Hobbs GA, Yen SH, Lee G

Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2010 OCT; 36 (6): 462-477

1898

12972 Bhat R, Xue YF, Berg S, Hellberg S, Ormo M, et al.

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418

JOURNAL OF BIOLOGICAL CHEMISTRY. 2003 NOV 14; 278 (46): 45937-45945

162

1899

15186 Bhatt MH, Podder N, Chokroverty S

Sleep and neurodegenerative diseases

SEMINARS IN NEUROLOGY. 2005 MAR; 25 (1): 39-51

1900

26440 Bhattacharjee A, Mulya A, Pal S, Roy B, Feldman GM, et al.

Monocyte 15-Lipoxygenase Gene Expression Requires ERK1/2 MAPK Activity

JOURNAL OF IMMUNOLOGY. 2010 NOV 1; 185 (9): 5211-5224

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records